1
Return

Synergistic effects of Tschimgine combined with 5-Fluorouracil against HT-29 human colorectal cancer cells

delete2026-08-11
delete0
delete
OA
AI
S
Shaghayegh Taheri
B
Bita Taghizadeh
H
Hossein Rafiei
F
Farshad Mirzavi *
M
Mohammad Soukhtanloo *
DOI:10.1186/s12906-026-05520-1delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Colorectal cancer (CRC) represents a leading cause of cancer morbidity and mortality globally. Tschimgine (Tsc), a naturally occurring terpenoid from Ferula ovina, has exhibited potent anticancer activity in preclinical models. However, its ability to enhance the sensitivity of CRC cells to 5-Fluorouracil (5-FU) remains unexplored. This study examined the pro-apoptotic and anti-metastatic properties of Tsc, both individually and in combination with 5-FU, in HT-29 human colorectal adenocarcinoma cells. HT-29 CRC cells and HFF human fibroblast cells were treated with Tsc, 5-FU, or their combination. Cell viability was assessed using the MTT assay. Apoptotic activity and cell cycle distribution were evaluated through flow cytometry. Migration capacity was tested using a scratch wound healing assay. Expression of apoptosis-related (Bax and Bcl-2) and metastasis-related genes (MMP-2 and MMP-9) was measured by qRT-PCR. Co-treatment with Tsc and 5-FU demonstrated a synergistic, dose-dependent reduction in HT-29 cell viability with minimal cytotoxicity toward HFF cells. Apoptosis was markedly enhanced in the combination group, evidenced by upregulated Bax and downregulated Bcl-2 expression. The combination also led to marked inhibition of cell migration and downregulation of MMP-2 and MMP-9. Tsc enhances 5-FU efficiency in inhibiting the growth and metastatic potential of HT-29 colorectal cancer cells. These results show the promising therapeutic effects of the combination of these two drugs, and more studies are needed to confirm their clinical use in the treatment of CRC.
Keywords:
Colorectal cancer
Tschimgine
5-fluorouracil
HT-29 cell line
Apoptosis
Anti-metastatic

Journal

B
BMC Complementary Medicine and Therapies
IF:
3.4
Papers:
273
Citations:
0

Organization

D
Department of Nutrition and Dietetics
Scholars:
110
Papers: 48
Citations: 0
P
pharmaceutical technology institute
Scholars:
54
Papers: 40
Citations: 0
C
cardiovascular diseases research center
Scholars:
4
Papers: 3
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers